Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income 258 M203 M187 M210 M192 M147 M 736 M Non-Operating Income, Total 20 M72 M-35 M-6 M-36 M10 M -67 M Interest expense, net of interest capitalized 22 M23 M22 M22 M22 M22 M 88 M Non-Operating Income, excl. Interest Expenses -2 M49 M-57 M-28 M-58 M-12 M -155 M Unusual income/expense —————— — Pretax income 229 M133 M135 M165 M65 M49 M 414 M Equity in earnings 53 M3 M20 M26 M31 M-11 M 66 M Taxes 44 M27 M21 M27 M-20 M9 M 37 M Non-controlling/minority interest 9 M3 M9 M19 M-3 M1 M 26 M After tax other income/expense —————— — Net income before discontinued operations 176 M103 M105 M119 M88 M39 M 351 M Discontinued operations —————— — Net income 176 M103 M105 M119 M88 M39 M 351 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 175 M103 M104 M117 M87 M39 M 347 M Basic earnings per share (Basic EPS) 3.492.12.22.61.940.88 7.62 Diluted earnings per share (Diluted EPS) 3.442.082.182.561.910.88 7.53 Average basic shares outstanding 50 M48.9 M47.4 M48.1 M44.9 M44.3 M — Diluted shares outstanding 50.7 M49.4 M48 M48.7 M45.4 M44.6 M — EBITDA 263 M208 M193 M216 M197 M152 M 758 M EBIT 258 M203 M187 M210 M192 M147 M 736 M Cost of revenue 45 M33 M-24 M24 M24 M9 M 33 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 5 M5 M6 M6 M5 M5 M 22 M